Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (331-340 of 364) with videos related to

Pageof 37
Sort By:
Science Advances|November 12, 2021
Control of lysosomal-mediated cell death by the pH-dependent calcium channel RECS1Philippe Pihán, Fernanda Lisbona, Janina Borgonovo, et al.
Blood|March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMMLMargaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Immunity|April 9, 2013
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cellsYuting Ma, Sandy Adjemian, Stephen R Mattarollo, et al.
JCI Insight|December 15, 2020
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockadeGladys Ferrere, Maryam Tidjani Alou, Peng Liu, et al.
Oncoimmunology|June 7, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncologyJenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Cell Death and Differentiation|May 12, 2021
Multifaceted modes of action of the anticancer probiotic Enterococcus hiraeAnne-Gaëlle Goubet, Richard Wheeler, Aurélie Fluckiger, et al.
Molecular Cancer Therapeutics|July 13, 2021
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses <i>In Vivo</i>Rocio Montes de Oca, Alireza S Alavi, Nick Vitali, et al.
The Journal of Clinical Investigation|May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancerMathieu Rouanne, Julien Adam, Camélia Radulescu, et al.
Nature Communications|April 4, 2019
Crizotinib-induced immunogenic cell death in non-small cell lung cancerPeng Liu, Liwei Zhao, Jonathan Pol, et al.
Cancer Discovery|October 13, 2020
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 DeficiencyJulie Le Naour, Peng Liu, Liwei Zhao, et al.
Pageof 37

Showing results (331-340 of 364) with videos related to

Sort By:
Pageof 37
Science Advances|November 12, 2021
Control of lysosomal-mediated cell death by the pH-dependent calcium channel RECS1Philippe Pihán, Fernanda Lisbona, Janina Borgonovo, et al.
Blood|March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMMLMargaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Immunity|April 9, 2013
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cellsYuting Ma, Sandy Adjemian, Stephen R Mattarollo, et al.
JCI Insight|December 15, 2020
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockadeGladys Ferrere, Maryam Tidjani Alou, Peng Liu, et al.
Oncoimmunology|June 7, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncologyJenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Cell Death and Differentiation|May 12, 2021
Multifaceted modes of action of the anticancer probiotic Enterococcus hiraeAnne-Gaëlle Goubet, Richard Wheeler, Aurélie Fluckiger, et al.
Molecular Cancer Therapeutics|July 13, 2021
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses <i>In Vivo</i>Rocio Montes de Oca, Alireza S Alavi, Nick Vitali, et al.
The Journal of Clinical Investigation|May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancerMathieu Rouanne, Julien Adam, Camélia Radulescu, et al.
Nature Communications|April 4, 2019
Crizotinib-induced immunogenic cell death in non-small cell lung cancerPeng Liu, Liwei Zhao, Jonathan Pol, et al.
Cancer Discovery|October 13, 2020
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 DeficiencyJulie Le Naour, Peng Liu, Liwei Zhao, et al.
Pageof 37